Long-acting opioid-agonists in the treatment of heroin addiction: why should we call them "substitution"?

Subst Use Misuse

Health and Human Development Section Division for Operations, United Nations Office on Drugs and Crime, Vienna, Austria.

Published: June 2009

Many studies have documented the safety, efficacy, and effectiveness of long-acting opioids (L-AOs), such as methadone and buprenorphine, in the treatment of heroin addiction. This article reviews the pharmacological differences between L-AO medications and short-acting opioids (heroin) in terms of reinforcing properties, pharmacokinetics, effects on the endocrine and immune systems. Given their specific pharmacological profile, L-AOs contribute to control addictive behavior, reduce craving, and restore the balance of disrupted endocrine function. The use of the term "substitution," referring to the fact that methadone or buprenorphine replace heroin in binding to brain opioid receptors, has been generalized to consider L-AOs as simple replacement of street drugs, thus contributing to the widespread misunderstanding of this treatment approach.

Download full-text PDF

Source
http://dx.doi.org/10.1080/10826080902810251DOI Listing

Publication Analysis

Top Keywords

treatment heroin
8
heroin addiction
8
methadone buprenorphine
8
long-acting opioid-agonists
4
opioid-agonists treatment
4
heroin
4
addiction call
4
call "substitution"?
4
"substitution"? studies
4
studies documented
4

Similar Publications

Background: Opioid dependence is a critical public health issue in Northeast India, with limited data available on the affected population.

Aim: This study examines the sociodemographic and clinical profiles of opioid-dependent individuals in Assam.

Methods: A retrospective review was conducted of 238 patients diagnosed with opioid dependence at a tertiary care addiction treatment center in Assam, covering records from January 2022 to January 2023.

View Article and Find Full Text PDF

Background And Aims: Opioid smoking is becoming more common in the United States. The aim of this analysis was to estimate relative mortality risk among those who primarily smoke opioids compared with those who inject.

Design: Retrospective propensity score-matched cohort analysis.

View Article and Find Full Text PDF

Opioid use disorder (OUD) affects over 40 million people worldwide, creating significant social and economic burdens. Medication for opioid use disorder (MOUD) is often considered the primary treatment approach for OUD. MOUD, including methadone, buprenorphine, and naltrexone is effective for some, but its benefits may be limited by poor adherence to treatment recommendations.

View Article and Find Full Text PDF

Objectives: This study aimed to describe the profile of women seeking treatment for the use of psychoactive substances in the city of Madrid. The study used a sample of 1968 women who sought treatment at the Addiction Care Centers (CAD) of the Madrid City Council in the year 2022, which accounted for 22.9 % of the total population attended.

View Article and Find Full Text PDF

Clinical trials of drugs, procedures, and other therapies play a crucial role in advancing medical science by evaluating the safety, efficacy, and optimal use of medical interventions. The design and implementation of these trials have evolved significantly over time, reflecting advancements in medicine, ethics, and methodology. Early historical examples, such as King Nebuchadnezzar II's and his captives' dietary experiment and Ambroise Paré's treatment of gunshot wounds, laid some foundational principles of trial design.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!